20-12-2025, 03:10

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Notified -
Globe Newswire20-12-2025, 03:10
10-12-2025, 17:35

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Notified -
Globe Newswire10-12-2025, 17:35
29-09-2025, 13:05

Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF

Notified -
Globe Newswire29-09-2025, 13:05
10-02-2025, 20:05

Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis

Notified -
Globe Newswire10-02-2025, 20:05